Evolent Health's Price Target Decreases by 32.38% to $6.01

Evolent Health's (EVH) average one-year price target has been revised to $6.01/share, a decrease of 32.38% from the prior estimate of $8.89/share. The price target represents an increase of 152.54% from the latest closing price of $2.38/share. Institutional ownership of EVH has decreased by 43.86% in the last quarter, with the put/call ratio indicating a bullish outlook.